TEPKINLY 4 mg/0,8 ml falc perf 4 mg 1 pce

7680691610028 CH-69161 L01FX27 07.16.1.

Active substances:

Epcoritamabum

No images available

Details

Product number
6916101
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
epcoritamabum 4 mg, natrii acetas trihydricus, acidum aceticum glaciale, sorbitolum 21.84 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 0.48 mg.

Articles (1)

Tepkinly 4 mg/0,8 ml, Injektionslösung
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
31/07/2026
Professional SmPC
Français
31/07/2026
Professional SmPC
Italien
31/07/2026

Detailed composition

Substance Quantity Type Category
epcoritamabum
4.0 MG Substance Wirkstoff (Principe actif)
natrii acetas trihydricus
- Substance HNIDK
acidum aceticum glaciale
- Substance HNIDK
sorbitolum
21.84 MG Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.48 MG Substance HBESI

Reimbursement information

Public price
CHF 565.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2025

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
69161
Drug name
Tepkinly 4 mg/0,8 ml, Injektionslösung
Galenic form
KOINJ
ATC Code
L01FX27
Authorization status
B
Dispensation category
A
First authorization
15/02/2024
Authorization expiration date
05/05/2027
IT number
07.16.1.
Domain
Human medicine
Field of application
Diffuses grosszelliges B-Zell-Lymphom; Follikuläres Lymphom

Packaging details

Description (FR)
TEPKINLY 4 mg/0,8 ml falc perf 4 mg 1 pce
Description (DE)
TEPKINLY 4 mg/0,8 ml Durchstf 4 mg 1 Stk
Market launch
10/03/2026
Narcotic (BTM)
No

Other packaging sizes

TEPKINLY 4 mg/0,8 ml falc perf 4 mg 1 pce
1 DUR
GTIN: 7680691610011
View
Buy us a coffee Explore the data